cancer semaglutide linked to GLP-1 drugs and cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 Clinical Impact of Semaglutide Beyond

Structurally, retatrutide is a 39-residue peptide assembled by solid-phase synthesis with three non-coded amino acid modifications: 2-aminoisobutyric acid (Aib) at positions 2 and 20 to confer DPP-4 resistance, and -methyl-leucine (MeL) at position 13 to optimize GIP receptor activity

For the right client, that is a very strong value proposition

Not medically dangerous, but it can affect body image and comfort

Patients should consult their healthcare provider to explore pricing options, coverage, and access

Researchers have looked at the role these medications can play in other addictive disorders, including drugs, alcohol, and tobacco

Moreover, tirzepatide elongated with exenatide (2939) would most likely show no evident effect